FDA opens early alert for Boston Scientific percutaneous catheter issue
The U.S. Food and Drug Administration has opened an early alert concerning a Boston Scientific percutaneous catheter, a device used in medical procedures, and says it is collecting additional information about the issue.
The FDA’s medical-device recall and early-alert page lists one Boston Scientific percutaneous-catheter issue dated July 24, 2026. The listing identifies the matter as an early alert rather than a completed recall classification.
What the FDA has identified
The available FDA entry identifies the company as Boston Scientific and the device category as a percutaneous catheter. It does not provide the product model, lot numbers, number of devices involved or a description of the failure mode.
The listing also does not state that the device caused injuries or deaths. No adverse-event finding is included in the approved information for the alert, and the available entry does not say how many devices may be affected.
The alert applies to medical devices distributed in the United States and appears in the FDA’s national system for medical-device recalls and early alerts. That system is intended to identify potentially serious corrections and recalls for healthcare providers and patients.
Why the classification matters
An early alert is not the same as a final recall determination. FDA guidance distinguishes early alerts from corrections and formal recalls, which are actions used to remove or correct devices that may violate safety requirements.
For this Boston Scientific device, the FDA has not identified the alert as a completed Class I recall in the available listing. Class I status therefore should not be inferred from the fact that the agency has opened an early alert.
The distinction is important because the alert indicates an active federal review, but it does not yet establish the full scope of the problem or the corrective action that may follow. The current record signals a potential patient-safety issue involving an invasive medical device while the agency gathers more information.
What remains unknown
The FDA listing available for this report does not identify the specific catheter model or the lots that may be involved. It also does not describe what went wrong, how many products were distributed, whether any patients were harmed or what steps Boston Scientific may be taking.
The available information likewise does not establish whether the issue affects every device in the broader percutaneous-catheter category. The agency’s listing names one Boston Scientific issue, but additional scope and distribution details require review of the underlying FDA communication.
Those omissions limit what patients, providers and other readers can conclude from the early alert alone. The notice confirms that FDA is examining the issue; it does not, by itself, provide a final assessment of risk or a completed recall order.
What happens next
The FDA says it is collecting information. The next known step is therefore continued review of the device issue and the underlying communication, including the details needed to determine its scope, risk and any appropriate corrective action.
Until that information is released, the approved FDA entry does not support identifying a specific affected model, lot, injury count or recall status beyond the early-alert designation dated July 24, 2026. Any later FDA update would be needed to establish whether the agency changes the classification or announces a formal correction or recall.
Sources
- Medical Device Recalls and Early Alerts, U.S. Food and Drug Administration
- Recalls, Corrections and Removals (Devices), U.S. Food and Drug Administration
Look for updates to this story
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.